Research Outputs
Research interests:
I am interested in studying the interactions between viruses and the immune system to decipher how viruses manage to counteract the immune system. I have been focusing on the humoral response against SARS-CoV-2 virus and the effector functions of antibodies.
Research articles:
First author:
IRF8 regulates efficacy of therapeutic anti-CD20 monoclonal antibodies. European Journal of Immunology, 2022
Sex differences in the evolution of neutralizing antibodies to SARS-CoV-2. Journal of Infectious Diseases, 2021
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies. Cell Reports Medicine, 2021
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations. Science Translational Medicine, 2020
Collaborations:
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies, Nature Communications, 2023
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2. Journal of Experimental Medicine, 2022
Dual TCR-alpha expression on MAIT cells as a potential confounder of TCR interpretation. Journal of Immunology, 2022
SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formation. EMBO, 2021
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection. Nature Immunology, 2021
Characteristics Associated with Olfactory and Taste Disorders in COVID-19. Neuroepidemiology, 2021
Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients, Nature Comminication, 2021
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies. Nature Medicine, 2021
SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020. Eurosurveillance, 2021
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France. EBioMedicine, 2020
Human Mucosal-Associated Invariant T Cells in Older Individuals Display Expanded TCRαβ Clonotypes with Potent Antimicrobial Responses. Journal of Immunology, 2020
Anti-HIV-1 antibodies trigger non-lytic complement deposition on infected cells. EMBO Reports, 2020
Human CD8+ T cell cross-reactivity across influenza A, B and C viruses. Nature Immonology, 2019
Single-Cell Approach to Influenza-Specific CD8+ T Cell Receptor Repertoires Across Different Age Groups, Tissues, and Following Influenza Virus Infection. Frontiers of Immunology 2018